Chargement en cours...
Clinical study of apatinib combined with EGFR‐TKI in the treatment of chronic progression after EGFR‐TKI treatment in non‐small cell lung cancer (ChiCTR1800019185)
This clinical trial (ChiCTR1800019185) is designed to be an open‐label, prospective, single‐center, single arm exploratory research study. The study will recruit non‐small cell lung cancer patients (NSCLC) with slow progression after first‐line treatment with EGFR‐TKI drugs. Slow progression will be...
Enregistré dans:
| Publié dans: | Thorac Cancer |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons Australia, Ltd
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049491/ https://ncbi.nlm.nih.gov/pubmed/31918452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13303 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|